MTT assay results after 72 h treatment showed that HGF caused a dose-dependent increase in breast cancer cells proliferation (Figure 2A) and the maximum effect was identified at 40 ng/ml of HGF (comparable to 100 ng/ml) in all three breast cancer cell lines (Figure 2A). The gene discussed is HGF; the disease is breast carcinoma.